Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vivus Qsymia Launch Includes Strategy To Overcome Medicare Hurdles

Aug 13 2012

• By Cathy Dombrowski

Related Content

Senate Wants FDA Plan To Speed Obesity Drug Development

Sep 07 2011

REMS For <em>Qsymia</em> Limits Distribution, But Vivus To Explore Expanding Access

Jul 23 2012

<em>Qsymia</em> Sales Reps Recruited For Experience With Metabolic Products

Jul 23 2012

What <em>Belviq</em> Labeling Means For Other Obesity Drug Sponsors

Jul 02 2012

Related Companies

Vivus, Inc.

Arena Pharmaceuticals, Inc.

Orexigen Therapeutics, Inc.

Additional Topics

Advertising, Marketing & Sales Launches BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window